ID   STK3_HUMAN              Reviewed;         491 AA.
AC   Q13188; A8K722; Q15445; Q15801; Q96FM6;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 2.
DT   05-OCT-2010, entry version 108.
DE   RecName: Full=Serine/threonine-protein kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=Mammalian STE20-like protein kinase 2;
DE            Short=MST-2;
DE   AltName: Full=STE20-like kinase MST2;
DE   AltName: Full=Serine/threonine-protein kinase Krs-1;
GN   Name=STK3; Synonyms=MST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AUTOPHOSPHORYLATION, AND TISSUE
RP   SPECIFICITY.
RX   MEDLINE=96144292; PubMed=8566796; DOI=10.1016/0378-1119(95)00653-2;
RA   Creasy C.L., Chernoff J.;
RT   "Cloning and characterization of a member of the MST subfamily of
RT   Ste20-like kinases.";
RL   Gene 167:303-306(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   MEDLINE=96413604; PubMed=8816758; DOI=10.1073/pnas.93.19.10099;
RA   Taylor L.K., Wang H.C., Erikson R.L.;
RT   "Newly identified stress-responsive protein kinases, Krs-1 and Krs-
RT   2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10099-10104(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-8; 13-43; 57-69; 85-91; 115-128; 133-141;
RP   149-178; 229-256; 267-298; 329-338; 382-403; 423-451; 462-467 AND
RP   474-485, ACETYLATION AT MET-1, AND MASS SPECTROMETRY.
RC   TISSUE=Mammary carcinoma;
RA   Bienvenut W.V., Matallanas D., Cooper W.N., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 96-203.
RX   MEDLINE=94100173; PubMed=8274451;
RA   Schultz S.J., Nigg E.A.;
RT   "Identification of 21 novel human protein kinases, including 3 members
RT   of a family related to the cell cycle regulator nimA of Aspergillus
RT   nidulans.";
RL   Cell Growth Differ. 4:821-830(1993).
RN   [9]
RP   INTERACTION WITH RAF1, AND ENZYME REGULATION.
RX   PubMed=15618521; DOI=10.1126/science.1103233;
RA   O'Neill E., Rushworth L., Baccarini M., Kolch W.;
RT   "Role of the kinase MST2 in suppression of apoptosis by the proto-
RT   oncogene product Raf-1.";
RL   Science 306:2267-2270(2004).
RN   [10]
RP   INTERACTION WITH SAV1, AND FUNCTION.
RX   PubMed=15688006; DOI=10.1038/sj.onc.1208445;
RA   Chan E.H.Y., Nousiainen M., Chalamalasetty R.B., Schaefer A.,
RA   Nigg E.A., Sillje H.H.W.;
RT   "The Ste20-like kinase Mst2 activates the human large tumor suppressor
RT   kinase Lats1.";
RL   Oncogene 24:2076-2086(2005).
RN   [11]
RP   INTERACTION WITH RASSF1.
RX   PubMed=16510573; DOI=10.1158/0008-5472.CAN-05-2951;
RA   Oh H.J., Lee K.-K., Song S.J., Jin M.S., Song M.S., Lee J.H., Im C.R.,
RA   Lee J.-O., Yonehara S., Lim D.-S.;
RT   "Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis.";
RL   Cancer Res. 66:2562-2569(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-316, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   FUNCTION, INTERACTION WITH SAV1, AND MUTAGENESIS OF LYS-56.
RX   PubMed=16930133; DOI=10.1111/j.1742-4658.2006.05427.x;
RA   Callus B.A., Verhagen A.M., Vaux D.L.;
RT   "Association of mammalian sterile twenty kinases, Mst1 and Mst2, with
RT   hSalvador via C-terminal coiled-coil domains, leads to its
RT   stabilization and phosphorylation.";
RL   FEBS J. 273:4264-4276(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; SER-316; SER-385 AND
RP   SER-444, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-316, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15; SER-316; SER-323;
RP   THR-325; THR-336; THR-384; SER-385; SER-392 AND SER-444, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-316, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-60.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Stress-activated, pro-apoptotic kinase which, following
CC       caspase-cleavage, enters the nucleus and induces chromatin
CC       condensation followed by internucleosomal DNA fragmentation. Key
CC       component of the Hippo signaling pathway which plays a pivotal
CC       role in organ size control and tumor suppression by restricting
CC       proliferation and promoting apoptosis. The core of this pathway is
CC       composed of a kinase cascade wherein MST1/MST2, in complex with
CC       its regulatory protein SAV1, phosphorylates and activates LATS1/2
CC       in complex with its regulatory protein MOB1, which in turn
CC       phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ.
CC       Phosphorylation of YAP1 by LATS2 inhibits its translocation into
CC       the nucleus to regulate cellular genes important for cell
CC       proliferation, cell death, and cell migration. MST1/MST2 are
CC       required to repress proliferation of mature hepatocytes, to
CC       prevent activation of facultative adult liver stem cells (oval
CC       cells), and to inhibit tumor formation. Phosphorylates NKX2-1 (By
CC       similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Inhibited by the C-terminal non-catalytic
CC       region. Activated by caspase-cleavage. Full activation also
CC       requires homodimerization and autophosphorylation of Thr-180,
CC       which are inhibited by the proto-oncogene product RAF1.
CC   -!- SUBUNIT: Homodimer; mediated via the coiled-coil region. Interacts
CC       with NORE1, which inhibits autoactivation (By similarity).
CC       Interacts with and stabilizes SAV1. Interacts with RAF1, which
CC       prevents dimerization and phosphorylation. Interacts with RASSF1,
CC       which leads to enzyme activation.
CC   -!- INTERACTION:
CC       Q9H4B6:SAV1; NbExp=2; IntAct=EBI-992580, EBI-1017775;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Note=The caspase-cleaved form cycles between nucleus
CC       and cytoplasm (By similarity).
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in adult kidney,
CC       skeletal and placenta tissues and at very low levels in adult
CC       heart, lung and brain tissues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SARAH domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U26424; AAC50386.1; -; mRNA.
DR   EMBL; U60206; AAB17261.1; -; mRNA.
DR   EMBL; AK291837; BAF84526.1; -; mRNA.
DR   EMBL; AP002087; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003355; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003467; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003551; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW91781.1; -; Genomic_DNA.
DR   EMBL; BC010640; AAH10640.1; -; mRNA.
DR   EMBL; Z25422; CAA80909.1; -; mRNA.
DR   IPI; IPI00942120; -.
DR   PIR; I38212; I38212.
DR   RefSeq; NP_006272.2; -.
DR   UniGene; Hs.492333; -.
DR   ProteinModelPortal; Q13188; -.
DR   SMR; Q13188; 13-297, 435-484.
DR   IntAct; Q13188; 7.
DR   STRING; Q13188; -.
DR   PhosphoSite; Q13188; -.
DR   OGP; Q13188; -.
DR   PRIDE; Q13188; -.
DR   Ensembl; ENST00000419617; ENSP00000390500; ENSG00000104375.
DR   GeneID; 6788; -.
DR   KEGG; hsa:6788; -.
DR   UCSC; uc003yip.1; human.
DR   CTD; 6788; -.
DR   GeneCards; GC08M099466; -.
DR   H-InvDB; HIX0007678; -.
DR   HGNC; HGNC:11406; STK3.
DR   HPA; CAB025316; -.
DR   HPA; HPA007120; -.
DR   MIM; 605030; gene.
DR   PharmGKB; PA36213; -.
DR   eggNOG; prNOG16822; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q13188; -.
DR   PhylomeDB; Q13188; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 26504; -.
DR   PMAP-CutDB; Q13188; -.
DR   ArrayExpress; Q13188; -.
DR   Bgee; Q13188; -.
DR   CleanEx; HS_STK3; -.
DR   Genevestigator; Q13188; -.
DR   GermOnline; ENSG00000104375; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; ISS:UniProtKB.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator a...; IDA:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0035329; P:hippo signaling cascade; IDA:BHF-UCL.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt recept...; IMP:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptosis; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR011524; SARAH.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
DR   PROSITE; PS50951; SARAH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; ATP-binding; Coiled coil; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    491       Serine/threonine-protein kinase 3.
FT                                /FTId=PRO_0000086689.
FT   DOMAIN       27    278       Protein kinase.
FT   DOMAIN      437    484       SARAH.
FT   NP_BIND      33     41       ATP (By similarity).
FT   COILED      287    328       Potential.
FT   COILED      442    475       Potential.
FT   COMPBIAS    308    314       Poly-Glu.
FT   COMPBIAS    370    375       Poly-Glu.
FT   ACT_SITE    146    146       Proton acceptor (By similarity).
FT   BINDING      56     56       ATP.
FT   MOD_RES       1      1       N-acetylmethionine.
FT   MOD_RES      15     15       Phosphoserine.
FT   MOD_RES     180    180       Phosphothreonine; by autocatalysis
FT                                (Probable).
FT   MOD_RES     316    316       Phosphoserine.
FT   MOD_RES     323    323       Phosphoserine.
FT   MOD_RES     325    325       Phosphothreonine.
FT   MOD_RES     336    336       Phosphothreonine.
FT   MOD_RES     384    384       Phosphothreonine.
FT   MOD_RES     385    385       Phosphoserine.
FT   MOD_RES     392    392       Phosphoserine.
FT   MOD_RES     444    444       Phosphoserine.
FT   VARIANT      60     60       V -> L (in an ovarian clear cell
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_041122.
FT   VARIANT     418    418       F -> C (in dbSNP:rs36047674).
FT                                /FTId=VAR_051670.
FT   MUTAGEN      56     56       K->R: Loss of activity.
FT   CONFLICT     96     98       WIV -> YLY (in Ref. 8; CAA80909).
FT   CONFLICT    121    121       D -> Y (in Ref. 8; CAA80909).
FT   CONFLICT    203    203       D -> G (in Ref. 8; CAA80909).
FT   CONFLICT    303    303       E -> D (in Ref. 1; AAC50386).
FT   CONFLICT    332    334       ESV -> GEC (in Ref. 1; AAC50386).
SQ   SEQUENCE   491 AA;  56301 MW;  84F598ED3617292C CRC64;
     MEQPPAPKSK LKKLSEDSLT KQPEEVFDVL EKLGEGSYGS VFKAIHKESG QVVAIKQVPV
     ESDLQEIIKE ISIMQQCDSP YVVKYYGSYF KNTDLWIVME YCGAGSVSDI IRLRNKTLIE
     DEIATILKST LKGLEYLHFM RKIHRDIKAG NILLNTEGHA KLADFGVAGQ LTDTMAKRNT
     VIGTPFWMAP EVIQEIGYNC VADIWSLGIT SIEMAEGKPP YADIHPMRAI FMIPTNPPPT
     FRKPELWSDD FTDFVKKCLV KNPEQRATAT QLLQHPFIKN AKPVSILRDL ITEAMEIKAK
     RHEEQQRELE EEEENSDEDE LDSHTMVKTS VESVGTMRAT STMSEGAQTM IEHNSTMLES
     DLGTMVINSE DEEEEDGTMK RNATSPQVQR PSFMDYFDKQ DFKNKSHENC NQNMHEPFPM
     SKNVFPDNWK VPQDGDFDFL KNLSLEELQM RLKALDPMME REIEELRQRY TAKRQPILDA
     MDAKKRRQQN F
//
